Hints and tips:
...The UK health and social care department said more courses had been used, without offering its own data....
...The Affordable Care Act of 2010 was intended to foster biosimilar competition, but did not live up to its title....
...The decision to withdraw from the scheme will not lower payments to the NHS from AbbVie, which makes one of the world’s best-selling drugs, Humira, and Eli Lilly, known for its diabetes drugs....
...“That [manufacturing] expertise will be important, especially with diabetes, which is more of a primary care market,” said Chen, adding that rivals Lilly and Novo Nordisk have experienced supply issues because...
...Sami Inkinen, chief executive of Virta Health, a telemedicine clinic focused on type 2 diabetes, said simply giving people more information was not enough....
...US-based Abbott Laboratories said earlier this week it was launching another antibody test for coronavirus, hoping to ramp up production to 20m in the US per month in June and beyond....
...“During the pandemic, there has been a huge increase in the burden of care work, due to closures of child care, elderly care and schools.”...
...Paul Abbott, chief executive of American Express Global Business Travel, described the deal as strategic, but added further consolidation in the industry was “inevitable” following a year of such disruption...
...Abbott said the test would start to be distributed to healthcare providers, such as doctor’s offices, urgent care clinics and emergency departments, this week. Shares in Abbott rose 7.2 per cent....
...He led the turnround of medical diagnostics maker Alere before overseeing its sale to Abbott in 2017 for $7.8bn including debt....
...Best from the journals Diabetes dangers Indian cities could be devastated by a jump in diabetes. Some 77m Indian adults currently have the disease, a number expected to almost double to 134m by 2045....
...Livongo, which uses technology tools such as coaching to help patients manage chronic ailments like diabetes, only went public in July last year at $28 a share....
...Mr Hudson also announced a simplification of Sanofi’s structure, with four core global business units to be reduced to three: speciality care covering immunology, rare diseases, rare blood disorders, neurology...
...Verily products like Onduo, a joint venture with Sanofi to create a diabetes management platform, might move closer to Google Health....
...P&G controls more than a quarter of the global market for baby care products....
...Shares in Merck were treading water pre-market despite the company boosting its target revenue range for the full year and reporting solid growth in its oncology, diabetes and hospital acute care products...
...Nuffield Council) Food as medicine A state-funded study in California is testing whether providing nutritious meals to chronically-ill poor people will affect their condition or the cost of their medical care...
...By encouraging patients to access these “lower-cost sites of care”, CVS predicts it can reduce the rate at which people use more expensive services such as hospitals and urgent care centres, leading to big...
...There are plenty of others, including St Jude Medical (acquired by Abbott Laboratories in January of this year), which is currently battling lawsuits relating to vulnerabilities in its implantable cardiac...
...Higher rates of liver dysfunction, diabetes and hypertension were recorded....
...Mr Anderes works for Froedtert & the Medical College of Wisconsin, which cares for about 700,000 patients a year....
...Johnson & Johnson warned over 100,000 diabetes patients of a flaw in their insulin pump, discovered by a researcher at cyber security company Rapid 7....
...The group said on Tuesday it would sell the units that make its feeding tubes and compression machines for deep vein thrombosis, as well as a patient care business that manufactures dressings for wounds,...
...I feel that she really cares if I make it or meet my goals [on diet and exercise]”, she adds....
...(American Institute for Cancer Research) Diabetes warning Type-1 and Type-2 diabetes significantly increased among younger people in the US between 2002 and 2012, particularly among minority racial and...
International Edition